Cargando…
Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition
Despite the initial effectiveness of the tyrosine kinase inhibitor lapatinib against HER2 gene-amplified breast cancers, most patients eventually relapse after treatment, implying that tumors acquire mechanisms of drug resistance. To discover these mechanisms, we generated six lapatinib-resistant HE...
Autores principales: | Rexer, Brent N., Ham, Amy-Joan L., Rinehart, Cammie, Hill, Salisha, Granja-Ingram, Nara de Matos, González, Ana María, Mills, Gordon B., Dave, Bhuvanesh, Chang, Jenny C., Liebler, Daniel C., Arteaga, Carlos L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204390/ https://www.ncbi.nlm.nih.gov/pubmed/21499296 http://dx.doi.org/10.1038/onc.2011.130 |
Ejemplares similares
-
Escape from HER family tyrosine kinase inhibitor therapy by the kinase inactive HER3
por: Sergina, Natalia V., et al.
Publicado: (2007) -
Nuclear Functions of the Tyrosine Kinase Src
por: Bagnato, Giulia, et al.
Publicado: (2020) -
H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation via heregulin production and activation of HER3
por: Chakrabarty, Anindita, et al.
Publicado: (2010) -
Protein tyrosine kinase 6 regulates activation of SRC kinase
por: Alwanian, Wanian M., et al.
Publicado: (2022) -
Auto-thiophosphorylation activity of Src tyrosine kinase
por: Cabail, M. Zulema, et al.
Publicado: (2016)